Offspring Biosciences AB is attending Nordic Life Science Days 2026 in Stockholm.

Offspring Biosciences is the Tissue-First Translational Partner for pharma scientists. We were founded to address the critical and potentially costly failure to address ‘Translational Gap’ in antibody development by moving beyond preclinical models and validating candidates in the only environment that matters: human disease tissue. We deliver decisive, quantitative insights with years of contextual experience that provide valuable 'go/no-go' confidence before the clinic.      The Mouse was Cured. The Patient Wasn't. Over 90% of antibody candidates that look promising in animal models ultimately fail in human trials, victims to the 'Translational Gap'. At Offspring Biosciences, we can help you bridge that gap. Our proprietary Tissue-Insights™ platform moves beyond subjective scoring to deliver Digital Truth. We answer not just if a drug binds, but where, how, and if it matters within the specific context of the human disease microenvironment. We transform ambiguous images into objective, AI-driven statistical datasets—turning 'Pixels into P-Values.' We combine the speed and flexibility of a boutique lab with the deep, pharma-grade expertise of the scientists who run it, allowing us to act as a true extension of your team. This helps us provide the responsive, scientific partnership required to solve complex translational problems. Our platform is proven. We are proud to have provided the key translational data that supported BioArctic's successful advancement of multiple ADPD therapeutics, proving its selective binding in human PArkinson's and Alzheimer's brain tissue. Stop guessing. Start validating with a partner that delivers clarity.